These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17475937)

  • 1. Islet-specific antibody seroconversion in patients with long duration of permanent neonatal diabetes caused by mutations in the KCNJ11 gene.
    Gach A; Wyka K; Malecki MT; Noczynska A; Skupien J; Nazim J; Szalecki M; Bodalski J; Sieradzki J; Mlynarski W
    Diabetes Care; 2007 Aug; 30(8):2080-2. PubMed ID: 17475937
    [No Abstract]   [Full Text] [Related]  

  • 2. Neonatal diabetes in a child positive for islet cell antibodies at onset and Kir6.2 activating mutation.
    Gach A; Wyka K; Pietrzak I; Wegner O; Malecki MT; Mlynarski W
    Diabetes Res Clin Pract; 2009 Nov; 86(2):e25-7. PubMed ID: 19692135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.
    Bremer AA; Ranadive S; Lustig RH
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):236-9. PubMed ID: 18221420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition from insulin to glyburide in a 4-month-old girl with neonatal diabetes mellitus caused by a mutation in KCNJ11.
    Chan YM; Laffel LM
    Pediatr Diabetes; 2007 Aug; 8(4):235-8. PubMed ID: 17659066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfonylrea treatment in permanent neonatal diabetes due to G53D mutation in the KCNJ11 gene: improvement in glycemic control and neurological function.
    Gurgel LC; Crispim F; Noffs MH; Belzunces E; Rahal MA; Moisés RS
    Diabetes Care; 2007 Nov; 30(11):e108. PubMed ID: 17965292
    [No Abstract]   [Full Text] [Related]  

  • 6. KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.
    Gloyn AL; Diatloff-Zito C; Edghill EL; Bellanné-Chantelot C; Nivot S; Coutant R; Ellard S; Hattersley AT; Robert JJ
    Eur J Hum Genet; 2006 Jul; 14(7):824-30. PubMed ID: 16670688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hyperglycemia in a 7-year-old child diagnosed with neonatal diabetes.
    Hathout E; Mace J; Bell GI; Njølstad PR
    Diabetes Care; 2006 Jun; 29(6):1458. PubMed ID: 16732049
    [No Abstract]   [Full Text] [Related]  

  • 8. Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation.
    D'Amato E; Tammaro P; Craig TJ; Tosi A; Giorgetti R; Lorini R; Ashcroft FM
    Diabet Med; 2008 Jun; 25(6):651-6. PubMed ID: 18544102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating [corrected] mutations: evidence for improvement in insulin sensitivity.
    Malecki MT; Skupien J; Klupa T; Wanic K; Mlynarski W; Gach A; Solecka I; Sieradzki J
    Diabetes Care; 2007 Jan; 30(1):147-9. PubMed ID: 17192350
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diabetes in infants may be treated with sulfonylurea as a replacement for insulin].
    Lauridsen MH; Boesgaard TW; Pedersen OB; Hansen T; Hertz B
    Ugeskr Laeger; 2009 Jun; 171(23):1923-4. PubMed ID: 19500515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities.
    Rica I; Luzuriaga C; Pérez de Nanclares G; Estalella I; Aragonés A; Barrio R; Bilbao JR; Carlés C; Fernández C; Fernández JM; Fernández-Rebollo E; Gastaldo E; Giralt P; Gomez Vida JM; Gutiérrez A; López Siguero JP; Martínez-Aedo MJ; Muñoz M; Prieto J; Rodrigo J; Vargas F; Castano L
    Diabet Med; 2007 Jul; 24(7):707-13. PubMed ID: 17490422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, Genetic, and Biochemical Characteristics of Early-Onset Diabetes in the Finnish Population.
    Huopio H; Miettinen PJ; Ilonen J; Nykänen P; Veijola R; Keskinen P; Näntö-Salonen K; Vangipurapu J; Raivo J; Stančáková A; Männistö J; Kuulasmaa T; Knip M; Otonkoski T; Laakso M
    J Clin Endocrinol Metab; 2016 Aug; 101(8):3018-26. PubMed ID: 27167055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [From injections to pills--neonatally diagnosed diabetes of mother and baby].
    Kaunisto K; Ojaniemi M; Juuti AK; Huopio H; Laakso M; Veijola R
    Duodecim; 2011; 127(6):559-62. PubMed ID: 21528521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical profile and etiology of diabetes mellitus with onset at less than 6 months of age.
    Valamparampil JJ; Chirakkarot S; Savida P; Omana S
    Kaohsiung J Med Sci; 2009 Dec; 25(12):656-62. PubMed ID: 19951851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Organ-specific autoantibodies in type I diabetic patients and their relatives].
    Campea L; Vela M; Candela A; Raponi MP; Napoleone E; Strappini P; Betterle C; Orsini M
    Recenti Prog Med; 1986 May; 77(5):226-32. PubMed ID: 3526459
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glycemic index of meals and postprandial glycemia in patients with permanent neonatal diabetes due to Kir6.2 gene mutations].
    Klupa T; Małecki M; Skupień J; Szalecki M; Jałowiec I; Surdej B; Myśliwiec M; Sieradzki J
    Przegl Lek; 2007; 64(6):398-400. PubMed ID: 18159846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulphonylurea treatment does not improve psychomotor development in children with KCNJ11 mutations causing permanent neonatal diabetes mellitus accompanied by developmental delay and epilepsy (DEND syndrome).
    Sumnik Z; Kolouskova S; Wales JK; Komarek V; Cinek O
    Diabet Med; 2007 Oct; 24(10):1176-8. PubMed ID: 17888143
    [No Abstract]   [Full Text] [Related]  

  • 18. Early glibenclamide treatment in a clinical newborn with KCNJ11 gene mutation.
    Däublin G; Lorenz-Depiereux B; Strom TM; Blankenstein O; Raile K
    Diabetes Care; 2007 Oct; 30(10):e104. PubMed ID: 17901525
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neonatal diabetes mellitus caused by KCNJ11 mutation: a case report].
    Wang SY; Zhang LJ; He ZQ; Tian Q; Li XD
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jan; 14(1):73-5. PubMed ID: 22289760
    [No Abstract]   [Full Text] [Related]  

  • 20. Permanent neonatal diabetes due to KCNJ11 gene mutation.
    Letha S; Mammen D; Valamparampil JJ
    Indian J Pediatr; 2007 Oct; 74(10):947-9. PubMed ID: 17978456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.